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Abstract
Celiac disease is an autoimmune disorder which can present with a variety of non-gastrointestinal
manifestations. In women, it may manifest with an assortment of gynecologic or obstetric
disorders. Some reports have linked female infertility with undiagnosed celiac disease. Though
there are a number of studies from Europe and the Middle East, only two prior American studies
have examined the prevalence of “silent” celiac disease in a female infertility population. We
prospectively performed serologic screening for celiac disease in 188 infertile women (ages 25–
39). While we did not demonstrate an increased prevalence of celiac disease in our overall infertile
female population, we were able to detect a significantly increased prevalence (5.9%) of
undiagnosed celiac disease among women presenting with unexplained infertility (n=51). Our
findings suggest the importance of screening infertile female patients, particularly those with
unexplained infertility, for celiac disease.
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Celiac disease is a chronic autoimmune disorder triggered by the ingestion of gluten, the
protein found in wheat, barley and rye. Classically the disease is manifested by symptoms of
diarrhea, flatulence and malabsorption, however, it is also associated with protean systemic
manifestations including metabolic bone disease, diabetes, thyroid dysfunction and lympho-
proliferative malignancies1. With improvements in screening serology for celiac disease,
more patients are being diagnosed due to non-gastrointestinal presentations.
Several studies have demonstrated implications of celiac disease on the reproductive health
of women. For instance, untreated maternal celiac disease may be associated with recurrent
fetal loss, 2, 3 intrauterine growth restriction, preterm delivery and low-birth weight. 4, 5, 6, 7
Reports have also suggested an association between gynecologic disorders such as
endometriosis8 or amenorrhea 7,9,10 and celiac disease.
Some series suggest a higher prevalence of undiagnosed celiac disease in patients with
infertility.3, 11, 12, 13, 14 The prevalence in these series ranges from 2–6% as compared with
almost 1% in the general population.14 Other authors do not show an increased
prevalence. 15,16 Establishing the actual prevalence of celiac disease in infertile populations
would be an important step in determining if any sub-groups of infertile patients should be
screened for the presence of celiac disease.
Overall, celiac disease is considered to occur in about 1% worldwide, with some variations
in different populations; higher rates being observed in European, Middle Eastern and North
African regions and much lower rates in Southeast Asian countries.17,1,18 Given the
prevalence variability and given that most of the earlier studies examining celiac disease
prevalence in infertile women were conducted in Europe (only two studies to date have been
conducted in the United States 14, 15), we attempted to determine the prevalence of celiac
disease in a more heterogeneous population of infertile North American women. Identifying
infertile woman with celiac disease would potentially be beneficial if a gluten-free diet could
improve fertility and pregnancy outcomes.
Methods
We enrolled 191 patients, ages 25–39, who presented to our center for care of either primary
or secondary infertility of at least 12 months duration. Patients were recruited on a volunteer
basis after study approval was obtained from our university’s Institutional Review Board.
We compared the prevalence of celiac disease in this infertile population to the expected
prevalence of celiac disease in this age range based on a well-defined population in the
United States (Olmstead County, Minnesota; J Murray, personal communication). For our
entire screened sample, we calculated the point prevalence of celiac disease with 95%
confidence intervals. We then repeated this prevalence estimate and comparison restricted to
those subjects who were deemed to have unexplained infertility.
Patients underwent basic infertility screening including ovarian reserve testing (day 2
estradiol and FSH and/or Anti-Mullerian Hormone (AMH) levels), hysterosalpingogram
(HSG), TSH, prolactin, and a semen analysis for the male partner. Several patients also
underwent laparoscopy to screen for endometriosis. Etiologies for infertility included
decreased ovarian reserve (MIS <0.4ng/ml or day 2 FSH >=12mIU/ml); male factor (if
semen analysis demonstrated at least one of the following: concentration <20million/ml,
motility<50%, morphology< 10%, using the Kruger comparison where normal >=15%);
tubal factor (if one or both of the tubes were occlued on HSG or if the patient reported a
prior history of ectopic); uterine factor, endometriosis, ovulatory dysfunction (either due to
polycystic ovarian syndrome or hypotholamic dysfunction) as well as unexplained (for
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patients who had normal results on basic infertility screening). The age range and types and
etiologies of infertility are shown in Table I.
All participating patients completed a questionnaire regarding the presence of
gastrointestinal symptoms.
Patients who were recruited into this study then underwent serologic screening for tissue
transglutaminase (TTG IgA, ELISA) and endomysial antibodies (EMA IgA). Due to the
known association of celiac disease with IgA deficiency, measurement of total IgA and anti-
gliadin antibodies (both AGA IgG and IgA) was performed to allow for the serologic
identification of potential subjects with coeliac disease and IgA deficiency. All serologic
testing was performed by Prometheus Laboratories (San Diego, California, United States).
Patients who tested positive on any of the celiac screening tests were informed of their
results and advised to seek follow up care with a gastroenterologist and undergo
confirmatory diagnosis with endoscopy and small intestinal biopsies. Histologically the
degree of villous atrophy was classified according to the modified Marsh criteria.18 Patients
with biopsy confirmed celiac disease underwent nutritional counseling on how to maintain a
gluten-free diet.
Results
Among the 191 patients, 3 were excluded because of missing laboratory data. The
demographic information and etiologies of infertility for the remaining 188 patients are
shown in Table I. Unexplained infertility was present in 51 patients (27%). Gastrointestinal
symptoms were common, reported by 55% of the cohort. The most common reported
gastrointestinal complaint was bloating (65%), however constipation was reported by 54%,
diarrhea 52%, nausea 26% and abdominal cramping 1%. A prior history of an irritable
bowel syndrome (IBS) diagnosis was reported by 8%. The prevalence of IBS in the patients
diagnosed with celiac disease was 50% in contrast to the 3% IBS prevalence in the
remaining 184 infertile patients (p=.0069, Fisher’s exact test).
Four of the 188 patients were diagnosed with celiac disease (Table II). The prevalence of
previously undiagnosed celiac disease in the cohort of 188 patients was 2.1% (95% CI,
0.8%–5.4%). The expected prevalence for CD in a similarly aged female population from
Olmtead County, MN, was 1.3%. A sub-group analysis of celiac disease prevalence in
women with unexplained infertility demonstrated a prevalence of 5.9% (95% CI, 1.5%–
17.2%). The expected prevalence based on the age distribution of these 51 patients was
1.3%.
Among the four patients with celiac disease, three were identified because of positive anti-
tTG IgA antibodies, while one patient with selective IgA deficiency had minimally elevated
AGA IgG. Symptoms, serology and endoscopic biopsy results for these four patients are
recorded in Table II.
All four patients underwent nutritional counseling concerning the gluten-free diet. All four
conceived within a year of their celiac diagnosis and diet changes. Patient A conceived
naturally within a month of her diagnosis and diet change. She delivered a healthy daughter
at term via primary Cesarean delivery due to fetal intolerance of labor. One month prior to
her celiac diagnosis and diet change, patient B underwent an abdominal myomectomy for a
rapidly enlarging intramural myoma (20cm in diameter). She conceived naturally four
months post-operatively and delivered a healthy daughter at term via primary Cesarean
section. Patient C conceived on her third cycle of gonadotropin/IUI therapy, eight months
after her celiac diagnosis and delivered a healthy term daughter via normal spontaneous
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vaginal delivery. Patient D conceived ten months after her celiac diagnosis through a frozen
embryo transfer cycle. She delivered healthy twin boys at 35+weeks via primary Cesarean
delivery after she experienced premature preterm rupture of membranes.
Additionally, there were 8 patients who tested positive for either AGA IgG or AGA IgA;
they were also advised to follow up with a gastroenterologist. None of these or other patients
in the cohort underwent endoscopy.
Discussion
In our screened population of infertile women 2.1% had celiac disease. This was not
significantly different from the prevalence in an aged matched North American population.
However, there was a statistically significant increased prevalence of celiac disease in
patients with unexplained infertility. The prevalence in this subgroup (5.9%) contrasts with
the findings of a recent American prospective cohort study which showed no increased
celiac disease prevalence in women with unexplained infertility (0.8%).15 Differences in the
ethnic background of patients in the two cohorts may partly explain this disparity. In our
study, all four patients who were diagnosed with celiac disease were Caucasian, and only
15% of the screened patients were of East Asian descent while 5% were of South Asian
background. In the Jackson series from northern California, 28% of the patients were of
general Asian descent. The prevalence of celiac disease is believed to be lower in Asian
populations than European or Middle-Eastern populations.18 But the prevalence appears to
be elevated in certain South Asian populations. 17, 18 Our findings are not dissimilar to those
from a very large (n=13, 145) study examining the prevalence of undiagnosed celiac disease
in American patients of both genders. That study reported a 6.25% prevalence of celiac
disease in patients presenting with “idiopathic” infertility though the genders of those
patients were not specified.14
Our findings raise the possibility that celiac disease is an important association of
unexplained infertility. All four patients with celiac disease in our series either reported
gastrointestinal symptoms (bloating, diarrhea, constipation) that are known to occur in those
with celiac disease, or prior history of IBS. In fact, there was a significantly increased
prevalence of IBS in the patients diagnosed with celiac disease compared to the IBS
prevalence in the infertile patients without celiac disease. Patients with IBS are known to
have an increased rate of celiac disease20 and it is considered to be cost effective to screen
for celiac disease.21 Therefore, it may be useful to inquire after these symptoms in patients
initially presenting for an infertility evaluation. For those patients presenting with both
unexplained infertility and any gastrointestinal complaints or history, screening for celiac
disease would be appropriate. In fact, given the significantly increased prevalence of celiac
disease found in our patients with unexplained infertility (as well as the supporting findings
in several previous studies), it may now be reasonable to screen any patient presenting with
unexplained infertility, regardless of the absence or presence of gastrointestinal symptoms.
Identifying celiac disease in infertile woman would be beneficial if institution of a gluten-
free diet could improve fertility and pregnancy outcomes. This hypothesis is plausible and
has been suggested by case reports22 and small prospective studies 23, 12. However, this
theory has not been rigorously evaluated in clinical trials. A gluten-free diet would be an
attractive infertility treatment option because of the relatively low cost and absence of
significant adverse effects compared to other infertility treatments. Identification of celiac
disease in infertile woman would also be helpful given the higher rate of serious illnesses
and mortality in patients with untreated celiac disease .24
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We believe that our testing protocol accurately identified patients with celiac disease. Early
generation screening tests that identified antibodies to gliadin, the chief antigenic agent in
gluten, were low in both sensitivity and specificity. Current tests for antibodies against tissue
translutaminase (TTG IgA) and endomysium are highly sensitive (90%–97%) and specific
(96%–100%) 25. Because up to 2.6% of patients with celiac disease will also have selective
IgA deficiency, our assays included a measurement of total IgA as well as AGA IgG
antibodies26. Patients with abnormal antibodies suggestive of celiac disease were advised to
seek expert gastroenterological evaluation.
Our study has several limitations. Despite the large volume of patients seen in our clinic,
many patients were reluctant to undergo further testing beyond their standard fertility
evaluation. Therefore, our sample size was limited. Since screening was voluntary and not
consecutive, there may be significant selection bias. Therefore the findings may not be
generalizable to other populations. However, our findings support the hypothesis that celiac
disease may be a potentially modifiable risk factor for unexplained infertility and strong
consideration should be given to screening all women presenting with unexplained infertility
for celiac disease. In the future, a large scale multi-center study prospectively evaluating the
prevalence of celiac disease in infertile woman could further clarify these issues.
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Table 1
Patient Demographics and Clinical Diagnosis
Number of Patients Enrolled (N) 188
Female Age (years)
   Mean±SEM 33.8±0.2
   Range 25–39
Female Patient Ethnicity N (%)
   Caucasian 119 (63.3%)
   East Asian 28 (15%)
   Hispanic 17 (9%)
   Indian-Asian 10 (5.3%)
   Black 10 (5.3%)
   Middle Eastern 4 (2.1%)
Etiology of Infertility N (%)
   Primary infertility 116 (62%)
   Secondary infertility 72 (38%)
   Male factor 53 (28.2%)
   Unexplained 51 (27.1%)
   Ovulatory dysfunction 25 (13.3%)
   Decreased ovarian reserve 23 (12.2%)
   Endometriosis 18 (9.6%)
   Tubal 14 (7.5%)
   Uterine 4 (2.1%)
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